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Prediction of miRNA-disease 
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MicroRNAs play critical roles in many physiological processes. Their dysregulations are also closely 
related to the development and progression of various human diseases, including cancer. Therefore, 
identifying new microRNAs that are associated with diseases contributes to a better understanding 
of pathogenicity mechanisms. MicroRNAs also represent a tremendous opportunity in biotechnology 
for early diagnosis. To date, several in silico methods have been developed to address the issue of 
microRNA-disease association prediction. However, these methods have various limitations. In 
this study, we investigate the hypothesis that information attached to miRNAs and diseases can be 
revealed by distributional semantics. Our basic approach is to represent distributional information on 
miRNAs and diseases in a high-dimensional vector space and to define associations between miRNAs 
and diseases in terms of their vector similarity. Cross validations performed on a dataset of known 
miRNA-disease associations demonstrate the excellent performance of our method. Moreover, the 
case study focused on breast cancer confirms the ability of our method to discover new disease-miRNA 
associations and to identify putative false associations reported in databases.
MicroRNAs (miRNAs) are a class of 19–24 nucleotide single-stranded non-coding RNAs that can regulate gene 
expression at the post-transcriptional level by binding with 3′ untranslated regions (UTRs) of the target mRNAs 
through base pairing. Every miRNA might regulate from a dozen to thousands of genes, and one target gene could 
also be regulated by hundreds of miRNAs. These miRNA-mRNA interactions play critical roles in many physi-
ological processes, such as development, apoptosis, differentiation and metabolism. Additionally, miRNA dys-
regulations are closely related to the development and progression of various human diseases, including cancer.
The amount of data gathered on this topic is still relatively low at the current time. To address this limit, math-
ematical modeling is an appropriate solution because it allows us to focus research and development effort on 
high-potential new associations of miRNA with diseases.
Because miRNAs act mainly by targeting mRNAs for cleavage or translational repression1, several modeling 
methods based on the characteristics of the targets were presented. From the similarity of the target mRNAs, 
Jiang et al.2 inferred a network that represents the similarities between miRNAs. By combining this network with 
known mRNA-disease associations, they estimated the correlation between the miRNAs and diseases. In subse-
quent work, they improved the accuracy of the method by accounting for the similarities between diseases3 and 
by incorporating the semantic similarity between miRNAs based on their Gene Ontology (GO) annotations4. 
Shi et al.5 also exploited the knowledge of target mRNAs by working at the level of the protein-protein interac-
tion network. They identified novel miRNA-disease associations by analyzing the links between proteins that are 
involved in a disease and proteins that are targeted by an miRNA. The problem with these types of approaches is 
that the number of experimentally verified miRNA-mRNA interactions is currently very low. To overcome this 
limitation, the authors used data that was generated by predictive programs that have high false-positive and 
false-negative rates6.
Based on the assumption that functionally related miRNAs tend to be associated with phenotypically similar 
diseases7,8, several methods have been proposed. Chen and Zhang9 designed a method to infer miRNA-disease 
associations using only the phenotypic similarities between those diseases. The performance of this method is 
limited in that it does not account for the similarities between miRNAs.
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Other research studies jointly use the functional similarities between miRNAs and the phenotypic similarities 
between diseases. Chen et al.10 predicted miRNA-disease associations using a random walk with restart algo-
rithm on a dataset composed of known miRNA-disease associations and miRNA-miRNA functional similarities. 
Later, they enriched their dataset with data regarding disease similarities and applied a method of regularized 
least squares to discover new miRNA-disease associations11. From an miRNA functional similarity network in 
which higher weights are attributed to links between miRNAs that belong to the same family or the same cluster, 
Xuan et al.12 proposed a method based on the weighted k-most similar neighbors.Two years later, they modeled 
the prediction process as a random walk on the same type of network13. The main problem with these approaches 
is that the functional similarities between the miRNAs remain largely unknown. All of the algorithms presented 
above are based on similarity scores that are calculated with the method of Wang et al.14, which estimates them 
from the similarities between related diseases.
The miRNA-disease network belongs to a specific class of networks (bipartite networks), whose nodes are 
divided into two sets, X and Y, and only connections between nodes in different sets are allowed. Recently, much 
attention has been given to bipartite networks, in particular, with regard to the question of how to assign weights 
to the links. Recommendation systems seek to predict the ‘preference’ or the ‘contribution’ from a node of one set 
to a node of the other set15. The work performed in this field can be fully applied to the prediction of the contribu-
tion of miRNAs to diseases. Li et al.16 used a recommendation system to predict miRNA-disease associations. The 
authors reported good results but also suggested some improvements, such as integrating miRNAs and disease 
similarities.
Jiang et al.17 presented a system that use a Support Vector Machine (SVM) to predict the associations between 
miRNAs and diseases. Some other studies, which are based on other supervised learning methods, can be found 
in the literature. However, the use of supervised methods implies having positive miRNA-disease associations but 
also negative miRNA-disease associations. This requirement is probably the largest drawback of such approaches.
In view of the work presented above, we can make several observations.
The first observation is that the quality of the prediction increases as the methods combine several sources of 
information. However, some of the biological knowledge that is available in the domain is under-used in existing 
programs. It is well known, for example, that members of the same miRNA family all share the same predicted 
targets18. It has also been reported that neighboring miRNAs show significant coexpression, which suggest a com-
mon regulatory pathway7,19. It is also obvious that knowledge regarding miRNA depicted in plain text in scientific 
studies contains valuable information.
The second observation is that each miRNA is associated with a set of heterogeneous data (associated diseases, 
targeted genes, distance from neighbors, plain text information) that makes it difficult to use traditional machine 
learning algorithms.
To solve these problems, we developed a method, called MiRAI, that uses distributional semantics to reveal 
new information that is attached to miRNAs and diseases.
Our basic approach represents distributional information on miRNAs and diseases in a high-dimensional 
vector space20,21 and defines the associations between miRNAs and diseases in terms of vector similarities.
The distributional hypothesis is the basis of statistical natural language processing; it states that the meaning 
of words can be determined by the context in which the words are used22. In our case study, we can consider that 
miRNAs represent words, and therefore, data associated with miRNAs play the role of context. By keeping the 
analogy, the goal is then to use the available information on the miRNAs as a whole (context) to infer new knowl-
edge regarding the miRNAs (words).
A vector space model is an algebraic model for representing objects as vectors. The principle is that each 
component of a vector is represented by a value (a weight) that should quantify the importance of a feature in the 
modelized object. Whole text studies use techniques such as Latent Semantic Analysis (LSA)23 to process vectors 
from a vector space model. For textual data, there are many ways to calculate the weights. Among these meth-
ods, variations of the popular term frequency–inverse document frequency weighting scheme (TF-IDF), which 
involves multiplying the Inverse Document Frequency measure by a Term Frequency measure21, are frequently 
used.
In our scenario, the vectors that represent the objects to be analyzed (miRNAs) are not homogeneous. In 
addition to associations between miRNAs and words extracted from plain text documents, we must also repre-
sent the relationships beween the miRNAs and diseases, targets, families or neighboring miRNAs. Links between 
miRNAs and diseases, targets or families consist of binary information that depends on the existence or not of an 
association. Neighboring relationships between miRNAs are expressed as integers that represent a distance along 
a chromosome in base pairs.
For textual data, for which LSA is well suited, we applied the TF-IDF weighting scheme. For other data, it was 
necessary to determine a weighting scheme that could represent the importance of the link between each miRNA 
and the associated data.
Results
Evaluation of the prediction performance. To evaluate the ability of our method to predict dis-
ease-miRNA associations, a five-fold cross-validation is performed. For a specific disease d, the dataset is ran-
domly partitioned into five equal sized subsets. Four of the five subsets are used to create the latent space, while 
the omitted subset is retained for querying and testing the model. In the testing test, all of the associations 
between miRNAs and d are removed. In addition, to be certain that the miRNAs are returned because of their 
underlying links with a disease and not because of some information found in the litterature, all of the data that 
originates from research studies are also removed. The cross-validation process is then repeated five times, with 
each of the five subsets used exactly once as the validation data.
www.nature.com/scientificreports/
3Scientific RepoRts | 6:27036 | DOI: 10.1038/srep27036
The latent space is then queried for the disease d to obtain a ranked list of miRNAs. The higher the miRNAs 
associated with d are ranked, the better the performance.
If an miRNA associated with d has a higher rank than a given threshold θ, it is considered to be a successful 
prediction, just as an miRNA that is not associated with d that has a rank lower than θ. However, because the 
choice of θ has a significant impact on the measures of performance, we used receiver operating characteristic 
(ROC)24 analysis, which combines in a single graph the trade-off between the false positive rate (FPR) and true 
positive rate (TPR) over the entire range of θ, where
=
+
=
+
TPR TP
TP FN
FPR FP
FP TN( ) ( )
and TP, TN, FP, and FN are the counts of true positives, true negatives, false positives, and false negatives, 
respectively.
A single measure of performance is obtained by computing the area under the ROC curve (AUC) (an AUC of 
1 reflects perfect classification and an AUC of 0.5 indicates random classification)24.
MiRAI was tested on the 83 human diseases that are stored in the human miRNA-disease database (HMDD)25, 
which are associated with at least 20 miRNAs.
The average AUC value obtained is 0.867 with a minimum of 0.624 for Lupus Vulgaris and a maximum 
of 0.987 for Hypertrophic Cardiomyopathy. Figure 1 shows the univariate distribution of the AUC scores. 
Figure 1 shows that few of the predictions (11 out of 82, 13%) are below 0.8. Only 2 diseases (Lupus Vulgaris and 
Adenoviridae Infections) obtain a score that is lower than 0.7. The scores obtained by our method are good over-
all. However, it is likely that the actual performance of our method is higher.
Lupus Vulgaris, which obtains the worst prediction, is associated with 62 miRNAs. In HMDD v2.0, 61 of these 
associations are obtained from a unique study (PMID:1899814026). The essential problem with this set of 61 asso-
ciations is that they are collected from a study that analyzes the microRNA expression patterns in renal biopsies 
of lupus nephritis patients. First, the associations are deducted from raw expression values and are not confirmed. 
Second, the data are not related to Lupus Vulgaris. Therefore, the score obtained by our method cannot be consid-
ered to be a bad result given that the data are not accurate.
Adenoviridae Infections, the second worst prediction, is associated with 74 miRNAs, but all of them are 
extracted from two tables in the article PMID:2063487827, which present the up-regulated and down-regulated 
miRNAs in adenovirus type 3 (AD3) infected Human laryngeal epithelial compared to controls. In this study, 14 
associations are truly confirmed from Q-PCR. It is not excluded that the 60 remaining associations, based only 
on miRNA expression, contain false positives. By keeping the 14 verified associations only, our method obtains a 
more significative AUC score of 0.796. This finding might indicate that the list actually contains false associations.
For diseases that are associated with many miRNAs, the inclusion of possibly false associations has an impact 
on the performance. For example, the miRNAs that are associated with breast neoplasm, one of the most-studied 
diseases, were extracted from 319 different studies. Of the 319 studies, 16 provided more than 10 associations.
We manually checked these studies and found that for 3 of them (PMID:2009927628 PMID:2195307129 and 
PMID:2224217830), the extracted associations were deducted from the miRNA expression level and not con-
firmed. By removing 40 dubious associations that come from these studies, the AUC score for breast neoplasm 
jumps from 0.864 to 0.891.
Figure 1. Univariate distributions of AUC scores. The small vertical ticks displayed on the horizontal axis 
correspond to the AUC values obtained for each of the 83 diseases. The AUC values were divided into bins of 
equal size. The vertical rectangles represent the number of cases for which the AUC value belong to each bin.
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By examining randomly some associations in HMDD v2.0, we determined that some of them concern raw 
expression data that is extracted from tables instead of truly confirmed associations. The inclusion of false posi-
tives in the dataset impacts all of the prediction results but more importantly the diseases that are associated with 
only a few miRNAs.
Comparison with other methods. Most of the studies that describe methods for miRNA-disease associ-
ations present the performances based on a set of well-studied diseases. To our knowledge, the state of the art is 
represented by MIDP13. In their study, Xuan et al.13 compared their method to 4 other methods and showed that 
MIDP is the best performing method. We compared our method to MIDP for the same set of 15 human diseases 
that are associated with many miRNAs (Table 1). The Area Under Curve (AUC) obtained by our tool ranged from 
0.796 to 0.928, with an average AUC value of 0.867. The performance is comparable to MIDP, which obtained 
AUC scores that range from 0.786 to 0.945, with an average of 0.862.
Because the MiRAI method is based on the similarities between miRNAs, it was expected that we would 
obtain good performance results for miRNAs that are associated with a large amount of data. What is more 
surprising is that the method perform equally well for diseases that are associated with only a few miRNAs. The 
average AUC value for the 27 diseases that are associated with 20 to 30 miRNAs is 0.875, with a minimum of 0.705 
for Rectal Neoplasms and a maximum of 0.987 for Hypertrophic Cardiomyopathy. The prediction results for all 
of the tested diseases are in Supplementary Table S1.
Identification of putative false associations. For each disease, our method produces a list of ordered 
miRNAs that are potentially associated with it. The miRNAs that have a high probability to be associated with 
a given disease are located at the beginning of the list, while the miRNAs that are not related to the disease are 
placed at the end. By looking at the ordered lists obtained for each testing set, we found out that some of the 
known associations are located at the very end of the list. This finding is illustrated by the ROC curves that reach 
100% for the false positive before all of the true positives are confirmed. Figure 2 shows the ROC curves that were 
obtained for Breast Neoplasms for each testing set. All of the curves show a rapid increase in the true positive 
rate (which corresponds to the discovery of positive samples) followed by a rather horizontal phase in which the 
negative samples are reported. These features are standard characteristics of ROC curves. However, the curves in 
Fig. 2 shows an abnormal pattern at the end, where the positive samples are discovered after most of the negative 
samples are reported. This finding suggests that the positive associations that are located at the very end of the 
predictions list might be potentially false. An miRNA-disease association is considered to be putatively erroneous 
if it is reported with our method with a false positive rate of above 0.85.
Systematic application of this criterion to all diseases leads to the generation of a list of 144 potential miRNAs 
that are falsely associated with 42 diseases (Supplementary Table S2).
Prediction of novel miRNA-disease associations. According to the same reasoning that is presented 
above, we suggest that miRNAs that are not associated with a disease that appears close to the begining of the list 
of candidates could be proposed as novel associations.
New miRNAs are considered to be potentially associated with a disease if the association is reported with a 
true positive rate of above 0.85. Systematic application of this criteria to all diseases leads to the generation of a list 
of 811 potential miRNAs associated with 93 diseases (Supplementary Table S3).
Disease name nb assoc MIDP MiRAI
Carcinoma, Hepatocellular 249 0.807 0.808
Breast Neoplasms 241 0.838 0.864
Stomach Neoplasms 207 0.821 0.815
Colorectal Neoplasms 171 0.845 0.864
Melanoma 165 0.837 0.849
Lung Neoplasms 156 0.876 0.904
Heart Failure 138 0.821 0.796
Prostatic Neoplasms 135 0.882 0.871
Carcinoma, Renal Cell 132 0.862 0.869
Ovarian Neoplasms 130 0.923 0.874
Glioblastoma 118 0.786 0.898
Pancreatic Neoplasms 118 0.945 0.928
Urinary Bladder Neoplasms 106 0.897 0.884
Carcinoma, Squamous Cell 94 0.870 0.883
Leukemia, Myeloid, Acute 77 0.913 0.895
AVERAGE 0.862 0.867
Table 1.  Prediction results for diseases associated with the largest number of miRNAs. The AUC scores of 
MiRAI are compared with the scores of MIDP, the best performing method so far.
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Case study: Breast Neoplasms. To confirm the robustness of our method and its ability to discover new 
information on major human pathologies, we present a case study for one of the most-studied diseases in the 
miRNA topic: breast neoplasm.
Table 2 shows the list of miRNAs that are known to be associated with Breast Neoplasms and that appear very 
far in the prioritized list of miRNAs that are associated with this disease. Among them, 9 miRNAs come from a 
table of differentially expressed miRNAs that are presented in a publication of Schrauder et al.30 (PMID:22242178, 
already discusses above). The 2 remaining miRNAs are examined in a study by van Schooneveld et al.31 
(PMID:22353773). The teams obtained results on circulating miRNAs (from blood or serum) that could be used 
as biomarkers to diagnose early stage breast cancer. According to Jarry et al.32, the conclusions based on circu-
lating miRNAs should be made with caution. The basic assumption in the studies on circulating RNA is that the 
most serious illness of a patient will significantly influence the quality and quantity of the miRNA found in blood. 
Several causes are responsive to miRNA liberation in vessels: secretions of miRNA33, inflammatory reactions34, 
cell destruction32, and minor diseases, among others.
Inflammatory reactions are a common process in immune responses. During cancer development, chronic 
activations of the inflammatory response have been observed35. These phenomena influence the pattern of cir-
culating miRNAs. Several articles36–38 show a link between miR-215 (a false positive) and inflammation. These 
results tend to confirm that the miRNAs listed in Table 2 are more implied in the general pathways of the immune 
response than in the carcinogenesis phenomena of breast cancers.
Blood is a multifactorial environment, and it is impossible for a physician to diagnose all of the diseases that 
are present in a patient at a given time. In these conditions, only specific miRNAs for a disease can be used as 
biomarkers. The works of Jarry et al.32 failed to show a specific pattern for breast cancer. The miRNAs previously 
quoted should be artefacts of the experiment according to our prediction method. The association of these miR-
NAs with Breast Neoplasms should be considered with caution.
Table 3 shows a list of 14 miRNAs that are predicted to be associated with Breast Neoplasms, whereas their 
associations are not reported in HMDD v2.0. Most of the associations are confirmed in the recent litterature. 
However, 11 associations were reported in studies that date from before the release of HMMM v2.0. This cir-
cumstance highlights the exhaustiveness limit of miRNA databases whose filling is still manual. Here, miR-208a, 
whose association with breast cancer is not reported in any research study, is proposed as a new miRNA that is 
associated with this disease.
Discussion
A new method based on a vector space model was implemented to predict potential miRNA candidates for 
diseases with known related miRNAs. Our approach integrates and makes use of various sources of information 
that are related to miRNAs. It exhibits encouraging results and will allow us to focus research effort on interesting 
Figure 2. ROC curves obtained at each testing set for Breast Neoplasms. Each color line illustrates the 
performance of MiRAI on one partition of the data. The curve is created by plotting the true positive rate (TPR) 
against the false positive rate (FPR) for all threshold settings. The best possible prediction method would yield a 
point in the upper left corner of the ROC space, which would represent 100% sensitivity (no false negatives) and 
100% specificity (no false positives). The diagonal line represents a worthless method that gives random results.
hsa-mir-1323 hsa-mir-1469 hsa-mir-215 hsa-mir-2355
hsa-mir-3130-1 hsa-mir-3130-2 hsa-mir-3186 hsa-mir-411
hsa-mir-4257 hsa-mir-4306 hsa-mir-718
Table 2.  List of false positive miRNAs associated with Breast Neoplasms.
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paths. Indeed, the costs of laboratory validations are still consequential and only a fraction of hypotheses can be 
humanly explored. Bioinformatics becomes the essential tool for modern research strategies.
Our work allowed associating new miRNAs with diseases. For diseases where the research efforts on miRNAs 
are less important, we suggest lists of putative candidates to target as a priority in future laboratory experiments. 
Some strange results were observed, which highlighted putative false associations that are stored in databases.
During cancer development, the chronic activations of the inflammatory response influence the pattern of 
circulating miRNAs35. Our method could provide a solution to this difficulty by highlighting the components 
that belong to this noise.
Methods
Data preparation. We downloaded the experimentally verified miRNA-disease associations from the 
human miRNA-disease database (HMDD) v2.0 of June, 14, 201425. As in previous studies11,13,14, all of the stem-
loop sequences that produce the same mature miRNA were merged into one group. Most of the miRNAs were 
associated with diseases that are included in the U.S. National Library of Medicine’s controlled vocabulary the-
saurus, the Medical Subject Headings (MeSH) terms. For the few disease names that are not listed in the MeSH, 
we manually mapped their names to the more relevant MeSH terms. After this pre-processing step, the dataset 
contained 10,737 associations between 559 miRNAs and 369 diseases. The miRNA targets were downloaded 
from the miRTarBase, which is a database for experimentally validated miRNA-mRNA interactions39. The dataset 
contains 48,030 associations between 1,886 miRNAs and 11,985 targets. For each miRNA, we also collected, from 
miRBase40, its family and its genomic location. Abstracts of the research studies that were associated with each 
miRNA in miRBase were also collected.
Creation of the matrices. The collected data contains, for each miRNA, its known associated diseases, its 
target mRNAs, its family, the distance to its neighbor miRNAs and abstracts of associated studies in plain text 
format. This result can be represented by 5 distinct matrices, each one holding a different type of association.
miRNA-disease associations. The miRNA-disease associations are stored in an m × d matrix MD = [xij], 
where m is the number of miRNAs, d is the number of different diseases, and xij is equal to 1 if an association 
between miRNA at position i and disease at position j is present in the dataset, or is 0 otherwise. The weights of 
the associations are then updated by the following function: = × =x max simil j k x( ( , ) )ij ik k
d
1 where simil is a sim-
ilarity measure that accounts for the distance between two diseases in the MeSH ontology. It is calculated with the 
formulae proposed by Lin41 using the implementation provided by the Semantic Measure Library42.
=
×
+
simil x y logP D
logP x logP y
( , ) 2 ( )
( ) ( )
0
were P(d) is the probability that a randomly selected disease is equal to d, and D0 is the most specific disease that 
subsumes both x and y.
miRNA-neighbor associations. The miRNA-neighbor associations are stored in an m × m matrix 
MN = [xij], where m is the number of miRNAs, and xij is a value that indicates the proximity of two miRNAs. 
Bandyopadhyay et al.7 and Baskerville et al.19 highlighted a significant coexpression of proximal pairs of miRNAs. 
They noted that beyond the 50 k range, the correlation drops abruptly. To mimic this correlation in the dataset, 
we transform a genomic distance to a weight, expressing the correlation between two miRNAs, with a sigmoid 
function of the following form:
miRNA name described in (PMID) publication date
hsa-mir-106a 19706389 Sept. 2009
hsa-mir-130a 23528537 Jun. 2013
hsa-mir-138-1 23300839 Dec. 2012
hsa-mir-138-2 23300839 Dec. 2012
hsa-mir-142 25406066 Nov. 2014
hsa-mir-144 25465851 Dec. 2014
hsa-mir-150 24312495 Dec. 2013
hsa-mir-15b 22908280 Sept. 2012
hsa-mir-181c 23524334 Jul. 2013
hsa-mir-19b-2 21059650 Jan. 2011
hsa-mir-208a
hsa-mir-30e 19432961 May 2009
hsa-mir-378a 20889127 Oct. 2010
hsa-mir-99a 21575166 May 2011
Table 3.  List of new miRNAs associated with Breast Neoplasms by our method.
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= −
+ − −
w dist
e
( ) 1 1
1 k dist dist( )0
where dist is the genomic distance between two miRNAs, dist0 is the sigmoid midpoint and is set to 6 × 105 (a 
distance of 60 kb is associated with a correlation of 0.5), and k is the steepness of the curve and is set to 2 × 10−4. 
This dataset contains 13682 associations between 1912 miRNAs.
miRNA-target associations. The raw data are stored in an m × t matrix M = [xij], where m is the number 
of miRNAs, t is the number of different target genes, and xij is equal to 1 if miRNA at position i targets the gene at 
position j and 0 otherwise.
The M matrix can be represented by a bipartite network that connects items from a set of miRNAs to items 
from a set of targets (Fig. 3a). Deducing the relations between the items of the same set is commonly performed 
using a one-mode projection. The one-mode projection produces a network that contains only nodes from the 
same set, where two nodes are connected when they have at least one common neighboring node from the other 
set. Figure 3b,c show the resulting networks after the miRNA and target projection, respectively. One-mode pro-
jections are frequently used as a similarity graph8,43,44. However, this transformation performed on the initial 
graph is quantitatively biased and produces a loss of information45.
To overcome this problem, Zhou et al.15 designed a weighting method that combines partial information given 
by one-mode projections to extract hidden information in the network. The method consists of two steps. First, 
resources associated to each node of the first set flow to nodes of the second set. When applied to Fig. 3a, the result 
indicates that miRNA a receives half of the resources of target α (a = α/2), b receives half of the resources of α and 
a third of the resources of β (b = α/2 + β/3), and so on. Second, new resources that are associated with nodes of 
the second set flow back to the first set. In the example of Fig. 3a, α receives all of the resources that are associated 
with a and half of the resources that are associated with b. Node α is now weighted with α/2 + (α/2 + β/3)/2 or 
3α/4 + β/6. The result can be represented by the following 4 × 4 matrix, which depicts the weighted one-mode 
target projection.
=






W
3/4 1/4 0 0
1/6 1/2 1/6 1/6
0 1/4 1/2 1/4
0 1/4 1/4 1/2
The weights of the targets correspond to the columns in matrix W. Thus, the weight of node α is specified in 
the first column of W (3/4 of node α + 1/6 of node β).
It is worthwhile to notice that the matrix is not symetrical. In our example, the resources that are associated 
with target α are computed by incorporating 1/6 of the resources that are associated with target β, however, in 
return, the contribution of target α to target β is 1/4. The MT matrix, which represents the weighted relationships 
between the miRNAs and targets, is calculated with the following formula.
= .MT M W
In the resulting matrix, the existing associations between an miRNA and a target are associated with a weight 
of ≤ 1, while non-reported associations can be assigned a weight of > 0. This method allows us to generate new 
associations that are based on the topology of the network. Figure 3d shows the weighted bipartite graph that is 
obtained after the processing of the graph in Fig. 3a. Solid links represent existing relationships, with new weights 
specified in blue. Dotted links, with weights written in red, are new implied associations.
miRNA-word associations. Associations between miRNA and words used in the abstract of the associated 
research studies are stored in an m × w matrix MW = [xij], where m is the number of miRNAs, w is the number of 
different words that are present in the associated documents, and xij is the weight of the miRNA at position i. The 
weight is calculated using the popular TF-IDF weighting scheme21.
miRNA-family associations. They are stored in an m × f matrix MF = [xij], where m is the number of 
miRNAs, f is the number of different miRNA families, and xij is equal to 1 if the miRNA at position i belongs to 
family j, or 0 otherwise. For this matrix only, the raw values are retained.
Combination of matrices. The matrices contain different types of data that are represented by real values 
that range from 0 to 1. A large matrix X that gathers all of the data available regarding miRNA is simply con-
structed by concatenating existing matrices.
= 

× × × × ×X MD MN MT MW MFm d m n m t m w m f( ) ( ) ( ) ( ) ( )
Dimensionality reduction. The goal of dimensionality reduction is to convert data of high dimensionality 
into data of lower dimensionality, which has the effect of bringing similar things together and pushing dissimilar 
things apart.
Singular Value Decomposition (SVD)46, which is the dimensionality reduction method used in Latent 
Semantic Analysis, is a matrix decomposition technique that can be used to transform data in a high-dimensional 
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space to a space of fewer dimensions. With SVD, the original matrix X is decomposed as a factor of three other 
matrices, U, Σ and V, as follow:
= ΣX U VT
where U is an m × m matrix, Σ is an m × n diagonal matrix with nonnegative real numbers on the diagonal, and 
VT denotes the transpose of V, an n × n matrix.
Figure 3. Illustration of miRNA-target associations. (a) miRNA-target bipartite network that connects 
items from a set of miRNAs to items from a set of targets. (b) One-mode miRNA projection that contains only 
nodes from the set of miRNAs. Two nodes are connected when they have at least one common connection to 
the same target. (c) One-mode target projection that contains only nodes from the set of targets. Two nodes are 
connected when they have at least one common connection to the same miRNA. (d) Weighted miRNA-target 
bipartite network. The graph is constructed in three steps: First, the resources that are associated with each 
miRNA node in graph (a) flow to the nodes that represent the targets. This operation indicates that miRNA 
a receives half of the resources of target α (a = α/2), b receives half of the resources of α and a third of the 
ressources of β (b = α/2 + β/3), and so on. Second, new resources that are associated with target nodes flow 
back to the nodes that represent the miRNAs. In the example, α receives all of the resources that are associated 
with a and half of the resources that are associated with b. Node α is now weighted with α/2 + (α/2 + β/3)/2 or 
3α/4 + β/6. Third, the weights are applied to the original miRNA-target network. In the new weighted graph, 
some of the connections that are present in the original graph appear with updated weights (black lines with 
weights specified in blue), while new connections are highlighted (dotted lines with weights specified in red).
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It is often useful to approximate X using only r singular values (with r < min(m, n)), in such a way that we have 
= Σ +X U V Er r r
T , where E is an error or residual matrix, Ur is an m × r matrix, Σ r is an r × r diagonal matrix, and 
Vr is an n × r matrix. The matrix = ΣX U Vr r r r
T is the matrix of rank r that best approximates the original matrix 
X. The proper choice of dimensionality is important. However, there is no general method for finding the optimal 
dimension. In this work, we determined the size by simulation. We tested the performance of the predictions for 
all of the dimensions between 50 and 500 with a step of 50 and found that using 400 dimensions was the choice 
that allows us to obtain better predictions. According to this result, Singular value decomposition (SVD) is 
applied on the combined matrix, and only the 400 first vectors are retained (r = 400).
Querying. In Xr, diseases and miRNAs are represented by vectors of length 400. Following the classical 
approach that is used in document indexing, the relatedness of two vectors is measured by their cosine distance. 
To obtain a ranked list of the miRNAs that are related to a disease d, queries are performed in the latent space by 
prioritizing the miRNA vectors by their distance to the vector of d.
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